(MedPage Today) — Patients with rheumatoid arthritis (RA) who used GLP-1 receptor agonists had less disease activity and improved cardiovascular biomarkers, a small retrospective study indicated.
Among 173 RA patients with overweight or obesity…
Source link : https://www.medpagetoday.com/rheumatology/arthritis/117429
Author :
Publish date : 2025-09-11 21:18:00
Copyright for syndicated content belongs to the linked Source.
